Publicly Listed MEI Pharma Completes $100 Million Private Placement to Build Litecoin Strategic Reserves
Odaily Planet Daily News: MEI Pharma announced the completion of a $100 million private placement, selling 29,239,767 shares of common stock or equivalent prepaid warrants at a price of $3.42 per share. The proceeds will be used to establish a Litecoin strategic reserve.
The company has also appointed Charlie Lee, founder of Litecoin and lead investor in this private placement, to its board of directors, and designated GSR as its digital asset and fund management advisor, responsible for overseeing the execution of the Litecoin reserve strategy. (businesswire)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
BUZZ - Harmony Biosciences CEO DeNardo to retire, COO to succeed; shares fall
UBS identifies the next main theme for AI trading: electricity, data centers, and key resources
UBS pointed out that the investment logic for AI is shifting from competition in models towards infrastructure development, with power supply, data center capacity, and financing capability becoming critical factors affecting industry expansion. As demand remains resilient, the importance of project delivery speed, supply chain security, and the provision of key raw materials is rising further. Companies that control scarce resources and infrastructure bottlenecks are expected to attract more market attention.
Crypto prices
More
